SanBio Co (TSE:4592) Accounts Payable & Accrued Expense : 円133.86 Mil (As of Jan. 2024)

View and export this data going back to 2015. Start your Free Trial

What is SanBio Co Accounts Payable & Accrued Expense?

SanBio Co's quarterly accounts payable & accrued expense declined from Jul. 2023 (円216.39 Mil) to Oct. 2023 (円81.39 Mil) but then increased from Oct. 2023 (円81.39 Mil) to Jan. 2024 (円133.86 Mil).

SanBio Co's annual accounts payable & accrued expense declined from Jan. 2022 (円462.64 Mil) to Jan. 2023 (円331.68 Mil) and declined from Jan. 2023 (円331.68 Mil) to Jan. 2024 (円133.86 Mil).

SanBio Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for SanBio Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SanBio Co Accounts Payable & Accrued Expense Chart

SanBio Co Annual Data

Trend

Jan15

Jan16

Jan17

Jan18

Jan19

Jan20

Jan21

Jan22

Jan23

Jan24

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

327.61

424.67

462.64

331.68

133.86

SanBio Co Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															331.68	291.53	216.39	81.39	133.86

SanBio Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

SanBio Co (TSE:4592) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SanBio Co Ltd (TSE:4592) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

SNBIF:USA

Address

8-1 Street Luke Tower 32nd Floor, Akashi-cho, Chuo-ku, Tokyo, JPN, 104-0044

Website

https://www.sanbio.com

SanBio Co Ltd is engaged in the research and development of regenerative cells drugs. The company has three types of drugs under development, including nerve regeneration cell SB623, used for the treatment of chronic cerebral infarction, traumatic brain injury, age-related macular degeneration, retinitis pigmentosa, Parkinson's disease, spinal cord injury and Alzheimer's disease; enhanced type-mesenchymal stem cells SB618, used to treat peripheral neuropathy, as well as muscle stem cells SB308, used in the treatment of muscular dystrophy.

SanBio Co (TSE:4592) Headlines

No Headlines